SYN TECH Chem & Pharm : Announcement of the board's resolution to set the transaction date that acquire the department spun-off from SCP, and the issuance of new shares.
Announcement of the board's resolution to set
the transaction date that acquire the department
spun-off from SCP, and the issuance of new shares.
Date of events
2022/06/08
To which item it meets
paragraph 53
Statement
1.Date of occurrence of the event:2022/06/08
2.Company name:Syn-Tech Chem. & Pharm. Co., Ltd.
3.Relationship to the Company (please enter "head office" or
"subsidiaries"):head office
4.Reciprocal shareholding ratios:NA
5.Cause of occurrence:
Syn-Tech has been approved by the board of directors on
March 16, 2021 and August 3, 2021 and submitted to the
shareholders' meeting on August 24, 2021. Syn-Tech will
accept the transfer of the synthesis department that
spinning-off from SCP, and this transaction will be in
exchange of 4,532,163 common shares, with a par value
of NT$ 10 per share and an issue price of NT$ 75.24
per share. The total amount of new shares issued is
NT$ 341,000,000. The case has been approved for recordation
per 19 May 2022 Public Announcement No. Securities-TPEx
-Supervision-1110004002 of the Taipei Exchange. The board
of directors has set July 1, 2022 as the transaction date
and the issuance of new shares.
6.Countermeasures:None.
7.Any other matters that need to be specified:None.
Attachments
Original Link
Original Document
Permalink
Disclaimer
SYN-Tech Chem & Pharm Co. Ltd. published this content on 08 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 June 2022 07:01:10 UTC.
SYN-TECH Chem. & Pharm. Co., Ltd. is a Taiwan-based company principally engaged in the production, processing and distribution of active pharmaceutical ingredients (APIs). The Companyâs main products consist of muscle relaxants, local anesthetics, cardiovascular agents, antipyretics, analgesics and anti-inflammatory drugs, antimicrobials, spirit stabilizers, intermediates and others. It is also engaged in the pharmaceutical agency business. The Company distributes its products within Taiwan market and to overseas markets, including Asia, Europe, the Americas and Africa.
SYN TECH Chem & Pharm : Announcement of the board's resolution to set the transaction date that acquire the department spun-off from SCP, and the issuance of new shares.
SYN-TECH CHEM. & PHARM. CO., LTD. 
